Diarrhea News and Research

Latest Diarrhea News and Research

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen Research & Development, LLC, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for ZYTIGA (abiraterone acetate) administered in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.

30 Aug 2012

March of Dimes emergency preparedness tips for pregnant women and new parents

Pregnant women evacuating their homes in advance of Hurricane Isaac should be sure to bring their medication, including their prenatal vitamins, as well as their medical records and their health care providers' emergency contact number.

29 Aug 2012

South Sudan refugee health situation 'alarming,' U.N. warns

"The situation of 170,000 Sudanese refugees living in camps and settlements across South Sudan's Unity and Upper Nile states is alarming and there are worries about an outbreak of cholera, U.N. refugee agency officials said on Friday," the Associated Press/Washington Post reports.

28 Aug 2012

Study explains how breast milk fosters colonies of microbiotic flora in a newborn's intestinal tract

The benefits of breast milk have long been appreciated, but now scientists at Duke University Medical Center have described a unique property that makes mother's milk better than infant formula in protecting infants from infections and illnesses.

28 Aug 2012

FDA approves Gilead’s Stribild to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Merz, Inc. today announced the acquisition of CUVPOSA (glycopyrrolate) oral solution for pediatric chronic severe drooling associated with neurologic conditions such as cerebral palsy.

27 Aug 2012

Lunch boxes and school eating areas are hotspots for bacteria

Canadian moms earn top marks when it comes to good hygiene practices, but a new study by Lysol and the Global Hygiene Council reveals they could do more to safeguard against bacteria hotspots in schools, especially at lunch time.

27 Aug 2012

Vandetanib shows efficacy in thyroid cancer

The tyrosine kinase inhibitor vandetanib could significantly extend progression-free survival in patients with locally advanced or metastatic differentiated radioiodine-refractory thyroid cancer, show results of a small phase II randomized trial.

24 Aug 2012

Antibiotics: do they affect contraceptives?

NPS MedicineWise has released information for consumers about taking antibiotics when also using hormonal contraceptives, explaining that there are only two antibiotics that affect how hormonal contraceptives work.

23 Aug 2012

Life-quality concerns for multiple myeloma survivors

Care of patients with multiple myeloma should not end with the achievement of long-term survival, suggests research indicating many experience poor health-related quality of life in the decade after diagnosis.

22 Aug 2012

Child mortality at double emergency rate in South Sudan refugee camp, MSF reports

"Children in a refugee camp in South Sudan are dying at more than twice the rate internationally recognized as an emergency, according to new figures released by Medecins Sans Frontieres (MSF)," the Guardian reports.

22 Aug 2012

Clinical trial to test whether fecal transplantation is effective in treating relapsing C. difficile

For patients with Clostridium difficile (C. difficile), a persistent and potentially deadly bacterial illness, severe diarrhea, abdominal pain, nausea and vomiting are an everyday event. This particularly virulent infection is prone to recurrence, even after multiple courses of expensive antibiotics, and treatment options are limited for patients who continually relapse or develop antibiotic resistance.

22 Aug 2012

FDA committee to review NPS’ Gattex NDA in October

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.

22 Aug 2012

Women in developing countries could play a major role in remedying sanitation and water crisis

People in ancient Rome 2,000 years ago had better access to clean water and sanitation that keeps disease-causing human excrement out of contact with people than many residents of the 21st century, a scientist said here today.

21 Aug 2012

Sierra Leone declares cholera outbreak a national emergency

"Sierra Leone has declared a cholera outbreak that has left 176 people dead since the start of the year a national humanitarian emergency, officials said Friday," AlertNet reports, adding, "Jonathan Abass Kamara, public relations officer for Sierra Leone's health ministry, said the outbreak was the worst in the West Africa country's history."

21 Aug 2012

Enzalutamide extends castration-resistant prostate cancer survival

Enzalutamide treatment significantly improves survival in men with castration-resistant prostate cancer, demonstrate phase III trial results published in TheNew England Journal of Medicine.

20 Aug 2012

Pennsylvania Department of Health reports four confirmed and six probable cases of H3N2v flu

The Pennsylvania Department of Health today reported four confirmed and six probable human cases of influenza due to a new strain of the flu known as H3N2v.

18 Aug 2012

Franchise clinics improve healthcare access for children in developing world

Franchise health clinics could substantially increase access to essential vaccinations and treatments among children living in low-income countries, regardless of their household income status, report researchers.

17 Aug 2012

Blog examines administration of zinc, rehydration salts to treat diarrhea in rural India

In this post in the PLoS "Speaking of Medicine" blog, guest blogger Oliver Sabot, executive vice president of the Clinton Health Access Initiative, "reflects on the challenge and opportunity of scaling-up access to effective treatment for diarrhea, the second largest cause of child mortality globally."

17 Aug 2012